Denali Therapeutics
DNLI
Rank 2161
Country USA
Exchange NASDAQ
Currency USD
Sector LIFE SCIENCES
Industry BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Address 161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, US
Denali Therapeutics - Key figures
Market cap 3.8 Billion
Revenue 82.88 Million
Profit -216,692,000
P/E Ratio No information
P/s Ratio 45.88
Denali Therapeutics - Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States.
The company is headquartered in South San Francisco, California.